Related Experiment Videos
Myocardial stunning and hibernation
1Department of Clinical Cardiology, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
Indian Heart Journal
|November 1, 1996
Summary
Hibernating myocardium, a reversible cause of left ventricular dysfunction, can improve with treatment. Identifying viable myocardium is key for revascularization decisions in patients with coronary artery disease (CAD).
Area of Science:
- Cardiology
- Cardiovascular Physiology
Background:
- Hibernating myocardium is a reversible cause of left ventricular (LV) dysfunction.
- Identifying viable myocardium is crucial for guiding revascularization strategies.
- Myocardial stunning, potentially leading to chronic LV dysfunction, is a clinically significant phenomenon.
Purpose of the Study:
- To explore the role of hibernating myocardium in left ventricular dysfunction.
- To emphasize the importance of identifying viable myocardium for revascularization decisions.
- To investigate the potential of pharmacological agents in treating chronic LV dysfunction caused by repeated stunning in coronary artery disease (CAD).
Main Methods:
- Review of existing literature on hibernating myocardium and myocardial stunning.
- Analysis of diagnostic criteria for identifying myocardial viability.
- Discussion of potential therapeutic targets for preventing stunning-induced LV dysfunction.
Main Results:
- Hibernating myocardium represents a reversible state of LV dysfunction.
- Successful identification of viable myocardium can lead to improved cardiac function and prognosis post-revascularization.
- Repeated episodes of stunning may contribute to the development of chronic LV dysfunction.
Conclusions:
- The identification of hibernating myocardium is critical for patient selection for revascularization.
- Pharmacological strategies aimed at preventing myocardial stunning could offer a novel treatment approach for chronic LV dysfunction in CAD patients.